Symptomatic treatment of acute, sub-acute and chronic respiratory disease of the upper and lower respiratory tract, where abnormal mucus of increased viscosity is present and where secretolysis is necessary or desirable.
Pronounced expectorant effects
Secondary antitussive action
An increase in the anti-atelectase factor which compensates for decreases in lung surfactant (lowered surface tension in the alveolar region caused by stress and disease)
Increased lung compliance
Concentrations of antibiotics in lung secretions
Sputolysinå¨ alters the constituents and viscosity of abnormal respiratory mucus and improves the efficiency of the respiratory tract clearance mechanism. A secondary antitussive action has also been demonstrated. The effect on mucus can change the character and frequency of a cough and alter the consistency and quantity of nasal discharges. Therefore, in some cases, there will be an initial increase in visible nasal discharges and/or frequency of cough prior to clinical improvement.
powder for oral administration